Zurich Cantonal Bank
AMLX icon

Zurich Cantonal Bank’s Amylyx Pharmaceuticals AMLX Stock Holding History

Zurich Cantonal Bank’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,877
Closed -$433K – 2596
2025
Q4 		$433K Buy
+35,877
New +$487K ﹤0.01% 1870

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Zurich Cantonal Bank's AMLX Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Amylyx Pharmaceuticals (AMLX) in Q1 2026: 40,790 shares worth $567K. The stake represents ﹤0.01% of the portfolio and ranks #1772 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in AMLX as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in AMLX in Q1 2023 and has held it in 9 quarters since. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Zurich Cantonal Bank held 40,790 shares of Amylyx Pharmaceuticals worth $567K as of Q1 2026.
  • Amylyx Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1772 holding.
  • Zurich Cantonal Bank first reported a position in Amylyx Pharmaceuticals in Q1 2023 and has held it in 9 quarters since.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.